Bendamustine and Rituximab Treatment, Chronic Lymphocytic Leukemia, Direct Antiglobulin Test, and False Negatives

Journal Title: Turkish Journal of Hematology - Year 2019, Vol 36, Issue 1

Abstract

.

Authors and Affiliations

Won Sriwijitalai, Viroj Wiwanitkit

Keywords

Related Articles

Aortic aneurysm and non-Hodgkin’s lymphoma in Marfan syndrome

The combination of Marfan syndrome with lymphoma is extremely rare. This report describes a case of Marfan syndrome who presented with chest discomfort and was diagnosed to have an aortic aneurysm and an additional incid...

Carbamazepine and Multiple Myeloma: Possible Interaction

Epilepsy is the most common chronic neurological disease and patients are treated by various classes of antiepileptic drugs [1]. In addition to their acute side effects, there are long-term adverse effects of antiepilept...

Health-Related Quality of Life, Depression, Anxiety, and Self-Image in Acute Lymphocytic Leukemia Survivors

Objective: With increasing survival rates in childhood acute lymphocytic leukemia (ALL), the long-term side effects of treatment have become important. Our aim was to investigate health-related quality of life, depressio...

Download PDF file
  • EP ID EP548205
  • DOI 10.4274/tjh.galenos.2018.2018.0397
  • Views 94
  • Downloads 0

How To Cite

Won Sriwijitalai, Viroj Wiwanitkit (2019). Bendamustine and Rituximab Treatment, Chronic Lymphocytic Leukemia, Direct Antiglobulin Test, and False Negatives. Turkish Journal of Hematology, 36(1), 53-54. https://europub.co.uk/articles/-A-548205